Search results
AstraZeneca Gets Workers’ Covid-19 Faith Bias Suit Narrowed
Bloomberg Law· 22 hours ago‘s bid to dismiss some claims from workers who asserted religious objections to its Covid-19 vaccination mandate proved successful when a federal court ...
Novavax Stock Rallies In Pre-Market As Company Plans To Deliver Covid-19 Vaccine By September -...
Benzinga· 1 day agoNovavax Inc. NVAX shares surged after the company announced its plans to deliver a...
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
Forbes· 2 days agoThe American Society of Clinical Oncology held its annual conference in Chicago this past week,...
The Most Profitable Biotechnology Company in the World
Insider Monkey via Yahoo Finance· 7 days agoIn this article, we will be taking a look at the most profitable biotechnology company in the world. If you want to learn about more, head straight to the 15 Most Profitable Biotechnology Companies ...
Can Chemo Benefit Older Patients With Pancreatic Cancer?
Medscape· 11 hours agoBetter tools are needed to identify vulnerable older patients with metastatic pancreatic cancer who...
'Outstanding' Results for Osimertinib: Stage III EGFR+ NSCLC
Medscape· 3 days agoResults from the LAURA trial will change practice once its label gets expanded, experts said at the...
FDA panel rejects MDMA therapy for treating patients with PTSD
WSB Radio· 3 days agoAn independent advisory panel of the Food and Drug Administration on Tuesday rejected the use of...
Is Semaglutide the
Medscape· 4 days agoThere has been much hyperbole since the presentation of results from the SELECT cardiovascular outcomes trial (CVOT) at this year's European Congress on...
'Practice Changing' Trial for Inoperable Locally Advanced NSCLC
MedPage Today· 5 days agoEGFR testing now needed for all patients with stage III disease, experts say
How Messenger RNA Made The COVID Vaccines Possible
Science Friday· 12 hours agoThe following is an excerpt from The Catalyst: RNA and the Quest to Unlock Life’s Deepest Secrets by Thomas R. Cech. On January 10, 2020, Prof. Yong-Zhen Zhang of Fudan University in Shanghai ...
